Document is current
Any future updates will be listed below
-
Authors
Wolfgramm, Hannes https://orcid.org/0000-0002-6028-0046
Saade, Christopher https://orcid.org/0009-0002-2554-0241
Harms, Marco
Busch, Larissa M. https://orcid.org/0000-0002-9545-6355
Lange, Josephine
Schedlowski, Maximilian
Surmann, Kristin https://orcid.org/0009-0009-7305-3457
Gesell Salazar, Manuela https://orcid.org/0000-0002-6727-1978
Hentschker, Christian
Steil, Leif https://orcid.org/0000-0002-0733-8421
Michalik, Stephan https://orcid.org/0000-0002-6550-0132
Völker, Uwe https://orcid.org/0000-0002-5689-3448
Reder, Alexander https://orcid.org/0009-0005-3575-6849
-
Funding
Funding for this research was provided by:
Universitätsmedizin Greifswald
- License Information
-
More Information
Article History
Received: 3 March 2025
Accepted: 1 May 2025
First Online: 20 May 2025
Declarations
:
: Not applicable.
: Not applicable.
: Marco Harms and Kristin Surmann are the managing directors of the ProTec Diagnostics GmbH. ProTec Diagnostics holds the licence and produces the vector and the RNA dye used in this study. The company was founded on the basis of findings from the research in the frame-work of the research training group RTG2719 presented here. The present study was planned and conducted independently. All authors assure that the results presented are scientifically sound and that no improper interests have influenced the interpretation of the data.
